Compounds > sw033291

sw033291 and Colitis--Ulcerative

sw033291 has been researched along with Colitis--Ulcerative* in 1 studies

Other Studies

1 other study(ies) available for sw033291 and Colitis--Ulcerative

ArticleYear
Orally Bioavailable Quinoxaline Inhibitors of 15-Prostaglandin Dehydrogenase (15-PGDH) Promote Tissue Repair and Regeneration.
    Journal of medicinal chemistry, 2022, 11-24, Volume: 65, Issue:22

    15-Prostaglandin dehydrogenase (15-PGDH) regulates the concentration of prostaglandin E2

    Topics: Animals; Colitis, Ulcerative; Dinoprostone; Hydroxyprostaglandin Dehydrogenases; Mice; Quinoxalines

2022